Cargando…
Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
Central nervous system (CNS) is one of the largest killers of people’s health all over the world. The overactivation of the immune and inflammatory responses is considered as an important factor, contributing to the pathogenesis and progression of CNS disorders. Among all kinds of immune and inflamm...
Autores principales: | Shao, Bo-Zong, Cao, Qi, Liu, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131647/ https://www.ncbi.nlm.nih.gov/pubmed/30233319 http://dx.doi.org/10.3389/fnmol.2018.00320 |
Ejemplares similares
-
NLRP3 inflammasome and its inhibitors: a review
por: Shao, Bo-Zong, et al.
Publicado: (2015) -
Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020) -
Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020) -
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
por: Song, Limin, et al.
Publicado: (2017) -
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)